Dimerization of cell surface receptors in signal transduction

Cell

Volumn 80, Issue 2, 1995, Pages 213-223

  Heldin, Carl Henrik ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CELL SURFACE RECEPTOR; CYTOKINE; CYTOKINE RECEPTOR; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; TUMOR NECROSIS FACTOR;

AUTOPHOSPHORYLATION; DIMERIZATION; HUMAN; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR BLOCKING; REVIEW; SIGNAL TRANSDUCTION;

ANIMAL; HUMAN; MACROMOLECULAR SYSTEMS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASE; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, ANTIGEN; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOKINE; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION;

EID: 0028838012     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0092-8674(95)90404-2     Document Type: Review

References (112)

1. Molecular cloning and expression of the human interferon-y receptor
2. Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: implications for TNF receptor activation
3. Structural design and molecular evolution of a cytokine receptor superfamily
4. Emerging families of cytokines and receptors
5. The fourth immunoglobin domain of the stem cell factor receptor couples ligand binding to signal transduction
6. Ciliary neurotrophic factor/leukemia inhibitory factor/interleukin 6/oncostatin M family of cytokines induces tyrosine phosphorylation of a common setof proteins overlapping those induced by other cytokines and growth factors
7. The hetero-oligomeric antigen receptor complex and its coupling to cytoplasmic effectors
8. A Neu acquaintance for ErbB3 and ErbB4: a role for receptor heterodimerization in growth signaling
9. Homomeric interactions between type II transforming growth factor-p receptors
10. Platelet-derived growth factor receptor signals
11. Analysis of ig-α-tyrosine kinase interaction reveals two levels of binding specificity and tyrosine phosphorylated Ig-σtimulation of Fyn activity
12. Modular binding domains in signal transduction proteins
13. Granulocyte colony-stimulating factor receptor signaling involves the formation of a three-component complex with Lyn and Syk protein-tyrosine kinases
14. Dimerization of the extracellulardomain ofthe human growth hormone receptor by a single hormone molecule
15. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins
16. Released form of CNTF receptor a component as a soluble mediator of CNTF responses
17. Ligands for EPH-related receptor kinases that require membrane attachment or clustering for activity
18. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex
19. A single amino acid substitution in the exoplasmic domain of the human growth hormone (GH) receptor confers familial GH resistance (Laron syndrome) with positive GH-binding activity by abolishing receptor homodimerization
20. lck
21. Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNFlike activity
22. Functional and biochemical association of Hck with the LIF/IL-6 receptor signal transducing subunit gp130 in embryonic stem cells
23. Signalling by receptor tyrosine kinases
24. Efficient coupling with phosphatidylinositol 3-kinase, but not phospholipase Cy or GTPase-activating protein, distinguishes ErbB-3 signaling from that of other ErbB/EGFR family members
25. Transcription factor p91 interacts with the epidermal growth factor receptor and mediates activation of the c-fos gene promoter
26. Rational design of potent antagonists to the human growth hormone receptor
27. Growth and differentiation signals mediated by different regions in the cytoplasmic domain of granulocyte colony-stimulating factor receptor
28. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor
29. Prolactin induces phosphorylation of Tyr694 and Stat5 (MGF), a prerequisite for DNA binding and induction of transcription
30. Trk-t1 is a novel oncogene formed by the fusion of tpr and irk genes in a human papillary thyroid carcinoma
31. Ligand-induced IFNγ receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91)
32. lck: identification of novel intermolecular association
33. Dimerization of B-type platelet-derived growth factor receptors occurs after ligand binding and is closely associated with receptor kinase activation
34. A novel member of the interferon receptor family complements functionality of the murine interferon γ receptor in human cells
35. The types II and III transforming growth factor-p receptors form homooligomers
36. Specific human granulocyte-macrophage colony-stimulating factor antagonists
37. Cloning of a murine IL-11 receptor α-chain; requirement for gp130 for high affinity binding and signal transduction
38. An interleukin-4-induced transcription factor: IL-4 Stat
39. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling
40. Signaling by the cytokine receptor superfamily: JAKs and TATs
41. The cytoplasmic domain of the T cell receptor ζ chain is sufficient to couple to receptor-associated signal transduction pathways
42. Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases
43. Ligand-induced interaction between a- and p-type platelet derived growth factor (PDGF) receptors: role of receptor heterodimers in kinase activation
44. Evidence for a critical role for the cytoplasmic region of the interleukin 2 (IL-2) receptor γ chain in IL-2, IL-4, and IL-7 signalling
45. Cytokine signal transduction
46. Conversion of human interleukin-4 into a high affinity antagonist by a single amino acid replacement
47. B cell antigen receptor motifs have redundant signalling capabilities and bind the tyrosine kinases PTK72, Lyn and Fyn
48. Regulation of signal transduction and signal diversity by receptor oligomerization
49. Activation of T cells by a tyrosine kinase activation domain in the cytoplasmic tail of CD3ε
50. A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences
51. The TGF-β family and its composite receptors
52. Functional activation of Jakl and Jak3 by selective assocation with IL-2 receptor subunits
53. Receptors for transforming growth factor-β
54. Cytokine receptors and signal transduction
55. Critical cytoplasmic region of the interleukin-6 signal transducer gp130 is conserved in the cytokine receptor family
56. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase
57. The protein tyrosine kinase JAK1 complements defects in interferon-α/β and -γ signal transduction
58. Heterodimerization of the IL-2 receptor β- and γ-chain cytoplasmic domains is required for signalling
59. The tyrosine kinase encoded by the MET proto-oncogene is activated by autophosphorylation
60. Cytoplasmic domains of the interleukin-2 receptor β and γ chains mediate the signal for T-cell proliferation
61. The human interferon α/β receptor: characterization and molecular cloning
62. Distinct roles of the intracellular domains of transforming growth factor β type I and type II receptors in signal transduction
63. Mechanism of met oncogene activation
64. Nuclear magnetic resonance structure of an SH2 domain of phospholipase C-γ1 complexed with a3 high affinity binding peptide
65. SH2 and SH3 domains
66. Cell-type specific interaction of Neu differentiation factor (NDF/ heregulin) with Neu/HER-2 suggests complex ligand-receptor relationships
67. erbB4
68. Identification of c-erbB-3 binding sites for phosphatidylinositol 3′-kinase and SHC using an EGF receptor/c-erbB-3 chimera
69. Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: a mechanism of interreceptor kinase activation and transphosphorylation
70. Fc receptors: rubor redux
71. Antigen receptor tail clue
72. Oncogenic activation of tyrosine kinases
73. Cellular immunity to HIV activated by CD4 fused to T cell or Fc receptor polypeptides
74. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor
75. Induction by EGF and interferon-γ of tyrosine phosphorylated DNA binding proteins in mouse liver nuclei
76. A unique autophosphorylation site in the PDGF a-receptor from a heterodimeric receptor complex
77. c. chains with Jakl and Jak3: implications for XSCID and XCID
78. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors
79. Signal transduction by the high-affinity GM-CSF receptor: two distinct cytoplasmic regions of the common β subunit responsible for different signaling
80. Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activation
81. Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor
82. Two different subunits associate to create isoform-specific platelet-derived growth factor receptors
83. Activation of transcription by IFN-γ: tyrosine phosphorylation of a 91-kD DNA binding protein
84. A single phosphotyrosine residue of Stat91 required for gene activation by interferon-γ.
85. Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions
86. Ras-independent growth factor signaling by transcription factor tyrosine phosphorylation
87. Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin
88. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death
89. Identification and sequence of an accessory factor required for activation of the human interferon γ receptor
90. ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor
91. Immunological relationships between receptors for insulin and insulin-like growth factor I
92. Stabilization of an active dimeric form of the epidermal growth factor receptor by introduction of an inter-receptor disulfide bond
93. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130
94. Activation of a novel human transforming gene, ret, by DNA rearrangement
95. Molecular cloning of rat JAK3, a novel member of the JAK family of protein tyrosine kinases
96. Signal transduction by receptors with tyrosine kinase activity
97. Crystals of the complex between human growth hormone and the extracellular domain of its receptor
98. A protein tyrosine kinase in the interferon α/β signaling pathway
99. neu protein and EGF receptor modulates EGF receptor function
100. Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms
101. Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-γ signal transduction pathway
102. Homodimerization and constitutive activation of the erythropoietin receptor
103. A point mutation in the neu oncogene mimics ligand induction of receptor aggregation
104. Signal transduction by lymphocyte antigen receptors
105. The IRS-1 signaling system
106. A cascade of tyrosine autophosphorylation in the β-subunit activates the phosphotransferase of the insulin receptor
107. TGFP signals through a heteromeric protein kinase receptor complex
108. Mechanism of activation of the TGF-β receptor
109. Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-β
110. Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor
111. Stat3 and Stat4: members of the family of signal transducers and activators of transcription
112. JAK protein tyrosine kinases: their role in cytokine signalling